Biological and Psychological Markers After Intervention in Adults With GAD
Key facts
- Who runs it
- Hospital de Clinicas de Porto Alegre
- Where
- Brazil1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 36 people enrolled
- Started
- 21 Jun 2023
- Ended
- 25 Jun 2024
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- 'Transcranial Direct Current Stimulation - tDCS
- Record updated
- 12 August 2025
Who can take part
- Age
- 18 years to 60 years
- Sex
- Women only
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Adults under the age of 18
- GAD-7 ≥ 10
- Possibility of being present on previously agreed days
Who cannot take part
- have a self-reported severe disorder (psychosis, schizophrenia, substance abuse, major depression)
- having had seizures and epilepsy
- having presented substance use disorder (except Tobacco) in the last 6 months or Suicidal Ideation in the last 6 months
- have suffered any type of brain injury or surgery, heart disease or cranial defect
- Being in psychopharmacological treatment for depression
- HAM-D≥23 scale
- being pregnant or breastfeeding
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This clinical trial inestigates the effects of transcranial direct current stimulation (tDCS) on anxiety symptoms in adult women with clinically relevant anxiety levels. The intervention involves the application of low-intensity electrical current over the left dorsolateral prefrontal cortex (DLPFC) across twenty consecutive sessions. Participants are randomly assigned to either an active or sham stimulation group in a double-blind design. The study aims to evaluate changes in anxiety symptoms, emotional regulation, and physiological and molecular markers, including EEG activity, heart rate variability (HRV), and salivary levels of cortisol and interleukin-6 (IL-6) plasma. The findings are expected to support the development of complementary, low-cost, and non-pharmacological strategies for anxiety management.
The 2 groups in the trial
- responds to the placebo effect Intervention: Transcranial Direct Current Stimulation - tDCSPlacebo, for comparison
Patients will receive tDCS stimulation treatment dorsolateral prefrontal cortex. According to the 10-20 EEG system, the anode will be placed on the left F3 and the cathode on the contralateral F4. Placebo stimulation uses a current of 2 milliamps for the first 30 seconds and again for the last 30 seconds. The tDCS application time will be 20 minutes Device: s-tDCS - Intervention: tDCS is a therapeutic method that modulates the membrane potential, where anodic stimuli induce cortical excitability and cathodic stimuli reduce it Device: a-tDCS \- Intervention: tDCS is a therapeutic method that modulates the membrane potential, where anodic stimuli induce cortical excitability and cathodic stimuli reduce it
Treatment: 'Transcranial Direct Current Stimulation - tDCS
- No placebo effect responds Intervention: Transcranial Direct Current Stimulation - tDCSExisting treatment, for comparison
Patients will receive tDCS stimulation treatment dorsolateral prefrontal cortex According to the 10-20 EEG system, the anode will be placed on the left F3 and the cathode on the contralateral F4. Active stimulation uses a current of 2 milliamps for 20 minutes. Device: s-tDCS - Intervention: tDCS is a therapeutic method that modulates the membrane potential, where anodic stimuli induce cortical excitability and cathodic stimuli reduce it Device: a-tDCS \- Intervention: tDCS is a therapeutic method that modulates the membrane potential, where anodic stimuli induce cortical excitability and cathodic stimuli reduce it
Treatment: 'Transcranial Direct Current Stimulation - tDCS
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Biological and Psychological Markers After Trancranial Electrical Stimulation in Adults With Generalized Anxiety Disorder
- Record updated
- 12 August 2025